Login
Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO
The Cambridge, Massachusetts-based biotech priced 33.5 million shares at $20 each, topping the $625 million raised by Kailera Therapeutics in April
Reading view
Big Pharma lost in court — Congress must not bail it out
Patients in every other wealthy country already get the medications they need at prices their governments negotiated on their behalf.
Big Pharma lost in court — Congress must not bail it out
Patients in every other wealthy country already get the medications they need at prices their governments negotiated on their behalf.
The FDA is approving its first new sunscreen ingredient in more than 20 years
Bemotrizinol, long available in Europe, blocks both UVA and UVB rays and is cleared for adults and children 6 months and older
